Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Asahi Kasei to acquire Aicuris to accelerate growth in severe infectious diseases

Jim Cornall - March 4, 2026

biotech

Promising results for rare paediatric epilepsy treatment

Jim Cornall - March 3, 2026

biotech

Next-generation flu vaccine development financed by EU

Jim Cornall - March 3, 2026

biotech

Panome Bio looks to new metabolomics data solution for biomarker discovery and drug development

Jim Cornall - March 3, 2026

biotech

Valinor and Renew partner to generate largest neurological disease multi-omics dataset

Jim Cornall - March 2, 2026

biotech

New lab to speed up diagnostic innovation for biotech and pharma partners

Jim Cornall - March 2, 2026

biotech

Gallbladder cancer could soon be detected in blood

Jim Cornall - March 2, 2026

biotech

Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases

Jim Cornall - February 27, 2026

1...181920...78 Page 19 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0